Abstract Details
|
Activity Number:
|
605
|
|
Type:
|
Contributed
|
|
Date/Time:
|
Thursday, August 7, 2014 : 8:30 AM to 10:20 AM
|
|
Sponsor:
|
Biopharmaceutical Section
|
|
Abstract #313781
|
|
|
Title:
|
Design Optimizations and Implementation for Adaptive Clinical Trials: A Case Study for Cancer
|
|
Author(s):
|
Qiming Liao*+
|
|
Companies:
|
GlaxoSmithKline
|
|
Keywords:
|
Adaptive Design ;
Clinical trial ;
Oncology ;
Statistical Consideration ;
Drug Development
|
|
Abstract:
|
New drug development is a time-consuming and expensive process. There is in need of advancing innovation in research and development. The adaptive designed clinical trial, one of the innovations, is a method to promote use of pre-specified modifications in the design or statistical procedures of an ongoing trial based on early data generated from the trial and thus make a trial more flexible. In this presentation, we will discuss statistical considerations and implementation strategies. A case study from oncology clinical trial will be presented.
|
Authors who are presenting talks have a * after their name.
Back to the full JSM 2014 program
|
2014 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Professional Development program, please contact the Education Department.
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Copyright © American Statistical Association.